Boehringer Ingelheim brings 2 presentations to BPI 2026 in Boston, and exhibits at Booth 619. Its sessions cover modelling and downstream scale. One addresses how to qualify mechanistic models in process development, and another draws on large-scale manufacturing experience to make resin lifetime studies more scalable.
| Organization | BPI 2026 Attendance |
|---|---|
Boehringer Ingelheim Ingelheim, Germany | 1 Senior Scientist · 1 Associate Director, Development Operations Drug Substance |
Pharmaceutical company whose BioXcellence business offers contract manufacturing of mammalian and microbial biopharmaceuticals, from DNA to aseptic filling. | Booth Exhibiting at Booth 619 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 12:15pm–12:45pm Talk Thu Sep 24 11:30am–12:00pm |
Instantly find 20 buyers from Boehringer Ingelheim
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction